Delivery Order SPE2DB22D1202-SPE2DB24FVJN2
Award Date
8/1/24
Potential Completion Date
8/22/24
Potential Value
$20K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of LYNPARZA 150 MG TABLET UU 60S, a specialty pharmaceutical product. The contract has a firm fixed price of $39,098.88 and a completion date of January 24, 2024. It is a delivery order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LYNPARZA 150 MG TABLET UU 60S, a pharmaceutical product, with a ceiling value of $5,249.67 and an ultimate completion date of April 21, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of LYNPARZA 100 MG Tablet, a prescription medication. The contract has a ceiling value of $39,357.76 and an ultimate completion date of October 3, 2024. This contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds several Indefinite Delivery Contracts (IDCs) with federal agencies,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,271.84, is for the supply of LYNPARZA 100 MG TABLET UU 60S, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of March 14, 2025. The contract is not designated as a set-aside and was awarded as part of a larger Indefinite Delivery Contract...
This is a $10,567.60 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LYNPARZA 150 MG TABLET UU 120S, a pharmaceutical product, with an ultimate completion date of March 3, 2025. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,654.82, is for the delivery of Lynparza 150 mg tablets over the period ending on April 7, 2025. The contract is a firm-fixed-price, delivery order type, and does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $76,596.34 firm fixed-price contract is for the supply of LYNPARZA 150 MG TABLET UU 120S, a specialty medication. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to supply Lynparza 150 mg tablets. The contract has a ceiling value of $118,261.86 and a period of performance through October 21, 2024. The contract is a firm-fixed price type and is not associated with a set-aside program. AmerisourceBergen has been awarded numerous federal contracts by DLA and other agencies to provide a wide range of...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 100 mg Lynparza tablets. The contract has a ceiling value of $10,543.70 and runs through April 25, 2025. It is a Firm Fixed Price contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LYNPARZA 100 MG TABLET, a pharmaceutical product, with a ceiling value of $10,519.62 and a completion date of April 22, 2025. The contract is a Delivery Order under a Firm Fixed Price contract type. This award does not have a set-aside designation, indicating open competition....